Skip to content

Clinical trials

Observational Prostatic Hyperplasia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Phase: Observational Country / region: United States Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20081
20091
20131
20142
20152
20161
20184
20191
20202
20214
20233
20242
20252
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting9
Terminated5
Active, not recruiting4
Not yet recruiting2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation3
University of Kansas Medical Center3
Indiana Kidney Stone Institute2
Olympus Corporation of the Americas2
University of California, San Francisco2
Artann Laboratories1
Benaroya Research Institute1
Boehringer Ingelheim1
Duke University1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia35
Prostatic Neoplasms10
Lower Urinary Tract Symptoms8
Kidney Calculi4
Urinary Calculi3
Urinary Bladder Neoplasms2
Arteriovenous Malformations1
COVID-191
Erectile Dysfunction1
Kidney Neoplasms1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.